← Dashboard
Aug 04, 2026 04:27 AM ET
Catalyst
FDA/Bio
InnoCare Announces Orelabrutinib in Combination with Mesutoclax Granted Breakthrough Therapy Designation in China
Breakthrough Therapy Designation in China signals regulatory
What changed
Why it matters
Breakthrough Therapy Designation in China signals regulatory
Sources
eodhd
Related signals
PHASE 1 OF INDIA - US TRADE PACT HINGES ON SECTION 301 PROBE , OFFICIAL SAYS →
PITNEY BOWES OUTLINES PHASE 2 STRATEGIC REVIEW WHILE PUSHING NEAREST DEBT MATURITY TO MARCH 2029 - SEEKINGALPHA →
UNICYCIVE PLUMMETS FOLLOWING SECOND CRL FOR OLC FOR HYPERPHOSPHATEMIA - SEEKINGALPHA →
← Dashboard
Aug 04, 2026 04:27 AM ET